As shown in Figure 5C, stimulation with plasma from ILD patients led to increased proportions of NK-92 cells expressing the activating receptor NKG2D, the degranulation marker CD107a, and the cytokine IFN-γ, suggesting enhanced NK cell activation and function under disease-relevant conditions. This evidence concerns the gene KLRK1 and interstitial lung disease.